| 注册
首页|期刊导航|中国肿瘤生物治疗杂志|肺积方调控补体相关蛋白CFHR5/MBL2/C9抑制肺癌细胞迁移、侵袭及动物模型肺转移

肺积方调控补体相关蛋白CFHR5/MBL2/C9抑制肺癌细胞迁移、侵袭及动物模型肺转移

罗斌 王衍鸿 刘佳君 刘诗卉 陆鑫熠 李佳轩 阙祖俊 田建辉

中国肿瘤生物治疗杂志2024,Vol.31Issue(12):1194-1203,10.
中国肿瘤生物治疗杂志2024,Vol.31Issue(12):1194-1203,10.DOI:10.3872/j.issn.1007-385x.2024.12.004

肺积方调控补体相关蛋白CFHR5/MBL2/C9抑制肺癌细胞迁移、侵袭及动物模型肺转移

Feiji Formula inhibits the migration and invasion of lung cancer cells and lung metastasis in animal models by regulating complement-related proteins CFHR5/MBL2/C9

罗斌 1王衍鸿 2刘佳君 3刘诗卉 2陆鑫熠 2李佳轩 2阙祖俊 3田建辉4

作者信息

  • 1. 上海中医药大学附属市中医医院肿瘤临床医学中心,上海 200071||上海中医药大学附属龙华医院肿瘤科,上海 200032
  • 2. 上海中医药大学附属市中医医院肿瘤临床医学中心,上海 200071
  • 3. 上海中医药大学附属市中医医院肿瘤研究所,上海 200071
  • 4. 上海中医药大学附属市中医医院肿瘤临床医学中心,上海 200071||上海中医药大学附属市中医医院肿瘤研究所,上海 200071
  • 折叠

摘要

Abstract

Objective:To investigate the effects of Feiji Formula on the migration and invasion of lung cancer cells,as well as lung metastasis in animal models and explore its possible mechanisms.Methods:TNMplot,TCGA,and DAVID databases were used to analyze the expression of complement-related proteins(CFHR5[complement factor H-related protein 5],MBL2[mannose-binding lectin 2],C9[complement component 9])in lung metastatic tissues and their relationship with immune cell infiltration,as well as related biological processes and signaling pathways.A subcutaneous xenograft mice model was established using 2LL cells.Mice were administered 2 g/mL Feiji Formula decoction(0.2 mL per dose)via oral gavage for 21 days.The effects of Feiji Formula on the incidence of lung metastasis,the number of lung metastatic nodules,and the protein expression of CFHR5/MBL2/C9 in the lung tissues of the model mice were observed.Exosome tracing assay was performed to observe the secretion and uptake of exosomes by CTC-TJH-01 and H1299 cells.Different concentrations of Feiji Formula were applied to treat H1299 and CTC-TJH-01 cells,and its effects on cell viability,invasion,migration,and CFHR5/MBL2/C9 protein expression were detected by CCK-8,scratch healing assay,Transwell assay,and WB method.Results:Network pharmacology analysis showed that CFHR5/MBL2/C9 proteins were highly expressed in lung metastatic tissues(all P<0.05)and were closely related to the complement system involved in immune response regulation.Compared with the control group,the Feiji Formula group demonstrated a significant reduction in the number of lung metastatic nodules(P<0.05).Feiji Formula(0-200 μg/mL)had no significant effect on the viability of H1299 and CTC-TJH-01 cells(both P>0.05).Both CTC-TJH-01 and H1299 cells could secrete and uptake each other's exosomes.Compared with the 0 μg/mL control group,Feiji Formula at concentrations of 50-200 μg/mL significantly inhibited the migration and invasion abilities of H1299 and CTC-TJH-01 cells(P<0.05 or P<0.01),and significantly reduced the protein expression levels of CFHR5 and MBL2(P<0.05 or P<0.01).Notably,the expression level of C9 protein in CTC-TJH-01 cells increased only after treatment with 200 μg/mL Feiji Formula(P<0.05).Conclusion:Feiji Formula can inhibit the migration and invasion of lung cancer cells as well as lung metastasis in model mice by regulating complement-associated proteins CFHR5/MBL2/C9.This effect may be related to exosome-mediated intercellular communication.

关键词

肺积方/肺癌/转移/外泌体蛋白/补体系统

Key words

Feiji Formula/lung cancer/metastasis/exosome proteins/complement system

分类

医药卫生

引用本文复制引用

罗斌,王衍鸿,刘佳君,刘诗卉,陆鑫熠,李佳轩,阙祖俊,田建辉..肺积方调控补体相关蛋白CFHR5/MBL2/C9抑制肺癌细胞迁移、侵袭及动物模型肺转移[J].中国肿瘤生物治疗杂志,2024,31(12):1194-1203,10.

基金项目

国家自然科学基金青年项目(No.82104943) (No.82104943)

国家自然科学基金面上项目(No.82174245) (No.82174245)

上海市卫生健康委员会领军人才基金(No.2022LJ014) (No.2022LJ014)

上海市炎癌转化病证生物学前沿研究基地项目(No.2021科技03-12) (No.2021科技03-12)

岐黄工程·第五批全国中医临床优秀人才项目[No.国中医药人教函(2022)239号] (2022)

中国肿瘤生物治疗杂志

OA北大核心CSTPCD

1007-385X

访问量0
|
下载量0
段落导航相关论文